Medicine & Life Sciences
Prostate-Specific Antigen
100%
Membranes
56%
Prostatic Neoplasms
38%
Radiopharmaceuticals
36%
Ligands
27%
Neoplasms
24%
Molecular Weight
22%
Technetium
17%
Nanoparticles
16%
Peptides
14%
Solid-Phase Synthesis Techniques
14%
Urea
13%
Carbon Monoxide
12%
Fluorescent Dyes
11%
Lysine
11%
Carbonic Anhydrase IX
10%
Radioisotopes
10%
human FOLH1 protein
9%
Amino Acids
9%
Positron-Emission Tomography
9%
Alpha Particles
9%
Kidney
8%
1,4,7-triazacyclononane-N,N',N''-triacetic acid
8%
Formyl Peptide Receptor
7%
Chelating Agents
7%
Prodrugs
7%
Pharmacokinetics
7%
Metals
7%
Therapeutics
7%
Contrast Media
7%
Magnetic Resonance Imaging
7%
Hydrogen Bonding
7%
Theranostic Nanomedicine
6%
N,N'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine N,N'-diacetic acid
6%
Polymers
6%
fibroblast activation protein alpha
6%
Glutamate Carboxypeptidase II
6%
Single Photon Emission Computed Tomography Computed Tomography
6%
Imides
6%
Injections
5%
pyridine-2-thiol
5%
Imidazoles
5%
anthranilic acid
5%
Optical Imaging
5%
Poly(amidoamine)
5%
Molecular Imaging
5%
Single-Photon Emission-Computed Tomography
5%
pyridine
5%
Radioactivity
5%
Engineering & Materials Science
Antigens
57%
Ligands
52%
Membranes
36%
Peptides
33%
Imaging techniques
30%
Tumors
24%
Rhenium
24%
Amino acids
20%
Technetium
15%
Molecular imaging
14%
Theranostics
13%
Tissue
13%
Salicylic acid
12%
Magnetic resonance imaging
12%
Dextran
11%
Labeling
11%
Nuclear magnetic resonance
11%
Acids
11%
Photoacoustic effect
11%
Protons
10%
Screening
10%
Prodrugs
9%
Magnetic resonance
9%
Fluorescence imaging
9%
Hydrogen bonds
9%
Amines
9%
Derivatives
9%
Reagents
9%
Fluorescence
9%
Crystal structure
9%
Phenols
8%
Crystals
8%
Nanoparticles
8%
Polyethylene glycols
8%
Pyridine
7%
Characterization (materials science)
6%
Tumor Necrosis Factor-alpha
6%
Photodynamic therapy
6%
Nanoprobes
6%
Molecular weight
6%
RNA
6%
Hyaluronic acid
6%
Biomolecules
5%
Radioisotopes
5%
Heterografts
5%
Magnetic nanoparticles
5%
Alkylation
5%
Cell death
5%
Genes
5%
Chemical Compounds
Antigen
58%
Ligand
30%
Chelating Agent
24%
Contrast Medium
18%
Radiopharmaceutical
18%
Acid
13%
Donor
12%
MRI Contrast Agent
11%
Crystal Phase Property
10%
Coordination Sphere
10%
Positron
10%
Pharmacokinetics
10%
Aldimine
9%
Pyridine
8%
P21
8%
Oxygen Atom
8%
Photon Emission
8%
Small Interfering RNA
8%
Radioisotope
8%
Maleimide
8%
Metal
7%
Nanoparticle
7%
Reaction Yield
7%
Prodrug
7%
Amide
7%
Dextran
7%
Imide
7%
Proton
7%
Dendrimer
6%
Schiff Base
6%
Fluorescence
6%
Lysine
6%
Imine
6%
Crystal Structure
6%
Chemotactic
5%
Length
5%
Urea
5%